Novel Formulations and Line Extensions with Soft Capsule Technology
Advancements in soft capsule technology can enable the development of soft capsule formulations, which are becoming the preferred method of oral administration.
Klyaksun/Stock.adobe.com
Soft capsule formulation technology presents an advantage to certain drug substances by overcoming its solubility and physical constraints that may inhibit use of alternate dosage forms. The technology can provide a product differentiation advantage. The relatively established quality-by-design (QbD)-based formulation and process development approaches for soft capsules can result in a lower development cost, potentially reducing time-to-market. The soft capsule formulation technology is an ideal candidate for 505(b)(2) submission pathway, and at the same time best for emerging small-molecule pipelines. The availability of dedicated soft-capsule development and commercialization sites catering to a wide range of batch sizes fitting a spectrum of fill formulation types makes the technology highly accessible. The dosage form can be used to improve bioavailability of Class II and IV drug substances and improve product stability. Emergence of vegetarian capsule shell formulations annuls the dietary concerns stemming from use of animal-based gels. New developments in soft capsule technology allows for considering the dosage delivery system as one of the preferred solid oral formulations that can achieve a high rate of patient compliance.
Click here for a PDF of this article.Peer-reviewed research
Submitted: Aug. 3, 2022
Accepted: Sept. 2, 2022
About the authors
Sam Turner is director of Technology and Development; Naresh Talwar, PhD, is director of Product Development; and Ajay Pazhayattil*, M.Pharm, DBA, Ajay.Pazhayattil@capcium.com, is vice-president, Scientific and Regulatory Affairs; all at Capcium.
*To whom all correspondence should be addressed.
Article details
Pharmaceutical Technology
Volume 46, Number 11
November 2022
Pages: 32–35
Citation
When referring to this article, please cite it as S. Turner, N. Talwar, and A. Pazhayattil, “Novel Formulations and Line Extensions with Soft Capsule Technology," Pharmaceutical Technology 46 (11) 32–35 (2022).
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Drug Solutions Podcast: Applying Appropriate Analytics to Drug Development
March 26th 2024In this episode of the Drug Solutions Podcast, Jan Bekker, Vice President of Business Development, Commercial and Technical Operations at BioCina, discusses the latest analytical tools and their applications in the drug development market.
Legal and Regulatory Perspectives on 3D Printing: Drug Compounding Applications
December 10th 2024This paper explores the legal and regulatory framework around 3D drug printing, particularly for personalized medicine, considering regulatory compliance, business concerns, and intellectual property rights.
